These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 2478030)

  • 1. Effects of the CCK receptor antagonist L364,718 on pancreatic growth in adult and developing animals.
    Zucker KA; Adrian TE; Bilchik AJ; Modlin IM
    Am J Physiol; 1989 Oct; 257(4 Pt 1):G511-6. PubMed ID: 2478030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
    Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.
    Louie DS; Liang JP; Owyang C
    Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of high fat diet and cholecystokinin receptor blockade on pancreatic growth and tumor initiation in the hamster.
    Herrington MK; Permert J; Kazakoff KR; Pour PM; Zuker KA; Bilchik AJ; Adrian TE
    Carcinogenesis; 1993 May; 14(5):1021-6. PubMed ID: 7684953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced cholecystokinin mediates the inhibition of pancreatic growth induced by bile salts.
    Gomez G; Townsend CM; Green DW; Rajaraman S; Greeley GH; Thompson JC
    Am J Physiol; 1990 Jul; 259(1 Pt 1):G86-92. PubMed ID: 1695489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Action of the cholecystokinin antagonist L364,718 on gastric emptying in the rat.
    Green T; Dimaline R; Peikin S; Dockray GJ
    Am J Physiol; 1988 Nov; 255(5 Pt 1):G685-9. PubMed ID: 3056036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cholecystokinin and gastrin antagonists on pancreatic exocrine secretion stimulated by gastrin-releasing peptide.
    Terashima H; Debas HT; Bunnett NW
    Pancreas; 1992; 7(2):212-9. PubMed ID: 1553370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of endogenous and exogenous cholecystokinin and of infusion with the cholecystokinin antagonist L-364,718 on pancreatic and gastrointestinal growth.
    Axelson J; Håkanson R; Ihse I; Lilja I; Rehfeld JF; Sundler F
    Scand J Gastroenterol; 1990 May; 25(5):471-80. PubMed ID: 2359975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cholecystokinin receptor antagonist L364,718 increases food intake in the rat by attenuation of the action of endogenous cholecystokinin.
    Hewson G; Leighton GE; Hill RG; Hughes J
    Br J Pharmacol; 1988 Jan; 93(1):79-84. PubMed ID: 3349234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic digestive enzyme gene expression: effects of CCK and soybean trypsin inhibitor.
    Rosewicz S; Lewis LD; Wang XY; Liddle RA; Logsdon CD
    Am J Physiol; 1989 Apr; 256(4 Pt 1):G733-8. PubMed ID: 2468294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a gastrin-type receptor on rabbit gastric parietal cells using L365,260 and L364,718.
    Roche S; Bali JP; Galleyrand JC; Magous R
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G182-8. PubMed ID: 1996638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the importance of cholecystokinin in neonatal pancreatic growth and secretory development in guinea pigs.
    Herrington MK; Joekel CS; Vanderhoof JA; Adrian TE
    Pancreas; 1995 Jul; 11(1):38-47. PubMed ID: 7545293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
    Nylander AG; Chen D; Ihse I; Rehfeld JF; Håkanson R
    Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-related involvement of CCK in bombesin-induced pancreatic growth.
    Liehr RM; Reidelberger RD; Rosewicz S; Bussjaeger LJ; Solomon TE
    Regul Pept; 1992 Apr; 38(3):207-19. PubMed ID: 1375383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats.
    Li Y; Hao Y; Owyang C
    Am J Physiol; 1997 Sep; 273(3 Pt 1):G679-85. PubMed ID: 9316472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of endogenous cholecystokinin in pancreatic regeneration after cerulein-induced acute pancreatitis.
    Jurkowska G; Grondin G; Morisset J
    Pancreas; 1992; 7(3):295-304. PubMed ID: 1594550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L364,718 antagonizes the cholecystokinin-induced suppression of locomotor activity.
    Soar J; Hewson G; Leighton GE; Hill RG; Hughes J
    Pharmacol Biochem Behav; 1989 Jul; 33(3):637-40. PubMed ID: 2587606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of receptors for gastrin and CCK on gastric smooth muscle cells.
    Menozzi D; Gardner JD; Jensen RT; Maton PN
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G73-9. PubMed ID: 2473654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portacaval shunt increases the trophic effect of cholecystokinin on the rat pancreas.
    Nylander AG; Chen D; Rehfeld JF; Håkanson R
    Scand J Gastroenterol; 1993 Feb; 28(2):145-8. PubMed ID: 8441908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
    Dembiński A; Warzecha Z; Konturek SJ; Banas M; Cai RZ; Schally AV
    J Physiol Pharmacol; 1991 Sep; 42(3):263-77. PubMed ID: 1665365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.